BACKGROUND: Primary immunodeficiencies are a rare group of inborn diseases characterized by a broad clinical and genetic heterogeneity. Substantial advances in the identification of the underlying molecular mechanisms can be achieved through the study of patients with increased susceptibility to specific infections and immune dysregulation. We evaluated 3 siblings from a consanguineous family presenting with EBV-associated B-cell lymphoproliferation at an early age (12, 7½, and 14 months, respectively) and profound naive T-cell lymphopenia. OBJECTIVE: On the basis of the hypothesis of a rare inborn immunodeficiency of autosomal recessive inheritance, we sought to characterize the underlying genetic defect. METHODS: We performed genome-wide homozygosity mapping, followed by whole-exome sequencing. RESULTS: We identified a homozygous inherited missense mutation in the gene encoding Coronin-1A (CORO1A) in the 3 siblings. This mutation, p. V134M, results in the substitution of an evolutionarily conserved amino acid within the β-propeller domain, which abrogates almost completely the protein expression in the patients' cells. In addition to a significant diminution of naive T-cell numbers, we found impaired development of a diverse T-cell repertoire, near-to-absent invariant natural killer T cells, and severely diminished mucosal-associated invariant T cell numbers. CONCLUSIONS: Our findings define a new clinical entity of a primary immunodeficiency with increased susceptibility to EBV-induced lymphoproliferation in patients associated with hypomorphic Coronin-1A mutation.
BACKGROUND: Primary immunodeficiencies are a rare group of inborn diseases characterized by a broad clinical and genetic heterogeneity. Substantial advances in the identification of the underlying molecular mechanisms can be achieved through the study of patients with increased susceptibility to specific infections and immune dysregulation. We evaluated 3 siblings from a consanguineous family presenting with EBV-associated B-cell lymphoproliferation at an early age (12, 7½, and 14 months, respectively) and profound naive T-cell lymphopenia. OBJECTIVE: On the basis of the hypothesis of a rare inborn immunodeficiency of autosomal recessive inheritance, we sought to characterize the underlying genetic defect. METHODS: We performed genome-wide homozygosity mapping, followed by whole-exome sequencing. RESULTS: We identified a homozygous inherited missense mutation in the gene encoding Coronin-1A (CORO1A) in the 3 siblings. This mutation, p. V134M, results in the substitution of an evolutionarily conserved amino acid within the β-propeller domain, which abrogates almost completely the protein expression in the patients' cells. In addition to a significant diminution of naive T-cell numbers, we found impaired development of a diverse T-cell repertoire, near-to-absent invariant natural killer T cells, and severely diminished mucosal-associated invariant T cell numbers. CONCLUSIONS: Our findings define a new clinical entity of a primary immunodeficiency with increased susceptibility to EBV-induced lymphoproliferation in patients associated with hypomorphic Coronin-1A mutation.
Authors: Marjorie Côte; Mickaël M Ménager; Agathe Burgess; Nizar Mahlaoui; Capucine Picard; Catherine Schaffner; Fahad Al-Manjomi; Musa Al-Harbi; Abdullah Alangari; Françoise Le Deist; Andrew R Gennery; Nathalie Prince; Astrid Cariou; Patrick Nitschke; Ulrich Blank; Gehad El-Ghazali; Gaël Ménasché; Sylvain Latour; Alain Fischer; Geneviève de Saint Basile Journal: J Clin Invest Date: 2009-11-02 Impact factor: 14.808
Authors: D L Nagle; M A Karim; E A Woolf; L Holmgren; P Bork; D J Misumi; S H McGrail; B J Dussault; C M Perou; R E Boissy; G M Duyk; R A Spritz; K J Moore Journal: Nat Genet Date: 1996-11 Impact factor: 38.330
Authors: Birthe Jessen; Andrea Maul-Pavicic; Heike Ufheil; Thomas Vraetz; Anselm Enders; Kai Lehmberg; Alfred Längler; Ute Gross-Wieltsch; Ali Bay; Zuhre Kaya; Yenan T Bryceson; Ewa Koscielniak; Sherif Badawy; Graham Davies; Markus Hufnagel; Annette Schmitt-Graeff; Peter Aichele; Udo Zur Stadt; Klaus Schwarz; Stephan Ehl Journal: Blood Date: 2011-08-30 Impact factor: 22.113
Authors: Jana Pachlopnik Schmid; Chen-H Ho; Fabrice Chrétien; Juliette M Lefebvre; Gérard Pivert; Marie Kosco-Vilbois; Walter Ferlin; Frédéric Geissmann; Alain Fischer; Geneviève de Saint Basile Journal: EMBO Mol Med Date: 2009-05 Impact factor: 12.137
Authors: Christina S Yee; Michel J Massaad; Wayne Bainter; Toshiro K Ohsumi; Niko Föger; Andrew C Chan; Nurten A Akarsu; Caner Aytekin; Deniz Çagdas Ayvaz; Ilhan Tezcan; Özden Sanal; Raif S Geha; Janet Chou Journal: J Allergy Clin Immunol Date: 2015-10-21 Impact factor: 10.793
Authors: Divya Punwani; Barry Pelz; Jason Yu; Nicoleta C Arva; Kristian Schafernak; Karly Kondratowicz; Melanie Makhija; Jennifer M Puck Journal: J Clin Immunol Date: 2015-02-10 Impact factor: 8.317
Authors: Alisa M Goldstein; Elizabeth M Gillanders; Melissa Rotunno; Rolando Barajas; Mindy Clyne; Elise Hoover; Naoko I Simonds; Tram Kim Lam; Leah E Mechanic Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-05-28 Impact factor: 4.254